Resultados de la búsqueda 371-380 of 5784 for Phase

  1. Oncología (médica) - Ensayos clínicos

    Phase 2 is designed to evaluate the safety and efficacy of \[177Lu\]Lu FAP 2286 as monotherapy in participants with pancreatic ductal adenocarcinoma (PDAC), non ...

  2. Oncología (médica) - Ensayos clínicos

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  4. Oncología (médica) - Ensayos clínicos

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post ... The first part of the study includes the first two phases of therapy: Induction and ...

  7. Oncología (médica) - Ensayos clínicos

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  8. Hematología - Ensayos clínicos - Mayo Clinic

    The study will include a Phase 1 part to determine the recommended dose of JCAR017 monotherapy in subjects with relapsed or refractory CLL or SLL, followed by a ...

  9. Oncología (médica) - Ensayos clínicos

    Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients ... The study will be performed in two phases: Phase I will be performed ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...